GO:0034056 estrogen response element binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034056 (estrogen response element binding) describes the molecular function of proteins that bind the estrogen response element (ERE), a conserved promoter sequence that mediates estrogen-regulated gene expression.
• The principal ERE-binding proteins are estrogen receptor alpha (ERα, ESR1) and estrogen receptor beta (ERβ, ESR2), which bind EREs as ligand-activated transcription factors.
• ERE binding is sequence- and ligand-dependent: the exact ERE sequence and the bound ligand jointly control in vivo receptor occupancy at regulated genes.
• ERE-dependent transcription controls diverse physiology, including feeding behavior, β-secretase regulation in Alzheimer's disease, and prolactinoma progression.
• ERE-binding activity has been characterized as a potential biomarker of breast cancer behavior.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of ERE-binding proteins and their target elements.
Description
Estrogen response element binding (GO:0034056) is the molecular function of selectively interacting with the estrogen response element (ERE), a conserved sequence found in the promoters of genes whose expression is regulated in response to estrogen. This function is central to estrogen signaling because it converts a hormonal signal into a direct transcriptional output at defined genomic loci. The ERE is recognized by estrogen receptors, and the resulting DNA-bound complexes recruit transcriptional machinery that alters target-gene expression. Because ERE binding is the point at which endocrine signals intersect with the genome, it is a focal mechanism in reproductive biology, neuroendocrinology, and oncology. Researchers study ERE binding to understand how estrogen controls gene programs in normal physiology and how dysregulation of these programs contributes to disease. The function is experimentally tractable: receptor-ERE interactions can be measured biochemically, and the consequences of disrupting them can be tested genetically. As a result, GO:0034056 sits at the interface of molecular endocrinology, transcription regulation, and precision disease modeling.
estrogen response element binding At A Glance
| GO ID | GO:0034056 |
|---|---|
| GO term | estrogen response element binding |
| Ontology | molecular_function |
| Synonym | ERE binding |
| Major function | Binding to a conserved estrogen response element (ERE) in promoters of estrogen-regulated genes |
| Primary binding proteins | Estrogen receptor alpha (ESR1/ERα) and estrogen receptor beta (ESR2/ERβ) |
| Ligand dependence | Binding and downstream regulation are influenced by ligands such as 17β-estradiol and phytoestrogens |
| Sequence dependence | The exact ERE sequence influences in vivo receptor occupancy at regulated genes |
| Disease relevance | Breast cancer behavior, prolactinoma, Alzheimer's disease, and feeding-behavior regulation |
What Is GO:0034056?
In plain terms, GO:0034056 means the ability of a protein to physically bind an estrogen response element, which is a short conserved DNA sequence in the promoters of estrogen-regulated genes. The official QuickGO definition states that this molecular function is binding to an estrogen response element (ERE), a conserved sequence found in the promoters of genes whose expression is regulated in response to estrogen. The synonym ERE binding is used interchangeably. This function is a DNA-binding activity: it does not itself describe transcriptional activation, but it is the prerequisite step through which estrogen receptors and associated proteins engage estrogen-responsive promoters.
Why Is estrogen response element binding Important in Cell Biology?
Estrogen response element binding is important because it is the direct molecular link between estrogen availability and gene expression. Without ERE binding, estrogen receptors cannot engage the promoters of estrogen-responsive genes, and the downstream physiological and pathological effects of estrogen signaling are lost. This function underlies estrogen-dependent control of cell proliferation, neuroendocrine circuits, and disease-associated gene programs. Because ERE binding is sequence- and ligand-sensitive, it also provides a mechanistic explanation for how different estrogens, phytoestrogens, and receptor subtypes produce distinct transcriptional outcomes. For translational researchers, ERE-binding activity has been evaluated as a biomarker of breast cancer behavior, indicating its potential clinical relevance beyond basic mechanism.
• Defines the first step of direct estrogen-dependent transcriptional regulation at target promoters.
• Mediated primarily by ERα and ERβ, making it central to estrogen receptor biology.
• Controls cell proliferation in estrogen-responsive contexts such as prolactinoma.
• Contributes to sex-specific regulation of β-secretase in Alzheimer's disease.
• Influences feeding behavior through ERα ERE signaling in mice.
• Is modulated by phytoestrogens, linking diet-derived compounds to estrogen receptor DNA binding.
• Shows ligand- and sequence-dependent in vivo occupancy, explaining context-specific gene regulation.
• Has been characterized as a potential biomarker of breast cancer behavior.
• Provides a defined molecular function for interpreting hormone response element binding protein biology.
• Offers a tractable target for CRISPR-based causal testing of receptor-ERE interactions.
Molecular Mechanism of estrogen response element binding
Ligand-activated receptor engagement
In simple terms: Estrogen binds the receptor, and the receptor then becomes able to bind DNA.
The molecular biology of the β-estradiol-estrogen receptor complex involves formation of a ligand-bound receptor that can interact with the estrogen response element and influence cell proliferation. In this step, 17β-estradiol binding to ERα is associated with ERE-induced up-regulation of target genes such as CaBP-9k, linking ligand binding to promoter occupancy and gene activation. Thus, ERE binding is not constitutive but is coupled to the ligand-bound state of the receptor.
ERE sequence recognition
In simple terms: The receptor reads the exact DNA sequence of the response element.
The estrogen response element is a conserved sequence found in promoters of estrogen-regulated genes, and binding to this element is the defining activity of GO:0034056. The interplay between ERE sequence and ligands controls in vivo binding of estrogen receptor to regulated genes, indicating that sequence features are a determinant of occupancy. This sequence dependence helps explain why not all estrogen-responsive promoters are bound equivalently in vivo.
Receptor subtype contributions
In simple terms: Different estrogen receptors can bind the same element with different outcomes.
Both estrogen receptor alpha and estrogen receptor beta can bind the estrogen response element, and phytoestrogens modulate the binding response of these receptors to the ERE. This means ERE binding is not exclusive to one receptor subtype, and the identity of the bound receptor can shape the regulatory consequence. Hormone response element binding proteins have been described as novel regulators of vitamin D and estrogen signaling, further indicating that additional proteins can participate in or modulate ERE-directed regulation.
Ligand- and context-dependent regulation of occupancy
In simple terms: What the receptor binds to and where it binds depend on the ligand and the cellular context.
In vivo binding of estrogen receptor to regulated genes is controlled by an interplay between ERE sequence and ligands, so occupancy is context-dependent rather than fixed. This principle is consistent with observations that ERE-dependent mechanisms can operate in a sex-specific manner, as shown for β-secretase regulation in Alzheimer's disease. It is also consistent with ERα ERE signaling influencing feeding behaviors differently in male and female mice.
Downstream transcriptional and phenotypic consequences
In simple terms: Once bound, the receptor changes gene expression and cell behavior.
ERE binding leads to altered expression of target genes, as illustrated by ERE-induced CaBP-9k up-regulation promoting prolactinoma progression. In breast cancer research, estrogen response element binding proteins have been characterized as biomarkers of breast cancer behavior, connecting the molecular function to clinical phenotype. Together, these examples show that GO:0034056 is mechanistically upstream of proliferation, neuroendocrine regulation, and disease-associated gene programs.
Key Genes Involved in GO:0034056 estrogen response element binding
The following genes and proteins are directly implicated in estrogen response element binding or in the ERE-dependent regulatory axis described in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 (ERα) | Primary estrogen receptor that binds EREs and mediates estrogen-regulated transcription | Central to ERE binding, proliferation, prolactinoma, and feeding behavior studies |
| ESR2 (ERβ) | Estrogen receptor subtype that binds EREs and contributes to estrogen signaling | Phytoestrogen modulation of ERE binding and receptor-subtype comparisons |
| BACE1 (β-secretase) | Estrogen-responsive gene whose regulation involves an ERE-dependent mechanism | Sex-specific regulation in Alzheimer's disease models |
| CaBP-9k (S100G) | ERE-induced target gene up-regulated in prolactinoma | Links ERE binding to prolactinoma progression |
| ERE-binding proteins (biomarker panel) | Proteins whose ERE-binding activity correlates with breast cancer behavior | Characterized as biomarkers of breast cancer behavior |
| Hormone response element binding proteins | Novel regulators of vitamin D and estrogen signaling | Broadens the concept of ERE-binding regulation beyond classical receptors |
| Estrogen receptor complex components | Form the β-estradiol-estrogen receptor complex that binds ERE | Molecular biology of ERE binding and cell proliferation |
| Ligand-dependent receptor complexes | Mediate sequence- and ligand-dependent in vivo ERE occupancy | Interplay between ERE sequence and ligands |
| Phytoestrogen-responsive receptor complexes | Modulate ERα and ERβ binding to ERE | Dietary compound effects on ERE binding |
| ERα ERE signaling pathway components | Transduce ERE-dependent signals controlling feeding behavior | Sex-specific behavioral studies in mice |
| ERE-containing promoter constructs | Report ERE-dependent transcriptional regulation | Functional assays of ERE binding and target-gene activation |
| Estrogen-regulated gene promoters | Contain conserved ERE sequences | Definitional context for GO:0034056 |
| Breast cancer ERE-binding protein set | Candidate biomarkers of tumor behavior | Clinical correlation studies |
| Alzheimer's disease ERE-dependent regulators | Control β-secretase in a sex-specific manner | Neurodegeneration research |
| Prolactinoma ERE target genes | Drive tumor progression when up-regulated | Endocrine tumor models |
| Vitamin D and estrogen signaling regulators | Cross-talk with hormone response element binding proteins | Nuclear receptor signaling research |
How Is estrogen response element binding Regulated?
ERE binding is regulated at multiple levels. Ligand availability controls the ability of estrogen receptors to engage the ERE, as shown for the β-estradiol-estrogen receptor complex. The exact ERE sequence and the identity of the ligand jointly control in vivo binding of estrogen receptor to regulated genes. Phytoestrogens can modulate the binding response of ERα and ERβ to the ERE, indicating that exogenous compounds can alter this function. Hormone response element binding proteins have been proposed as novel regulators of vitamin D and estrogen signaling, suggesting additional regulatory layers. Finally, ERE-dependent regulation can be sex-specific, as demonstrated for β-secretase in Alzheimer's disease and for ERα ERE signaling in feeding behavior.
estrogen response element binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR1 (ERα) | Prolactinoma progression via ERE-induced CaBP-9k up-regulation | Knockout or point-mutation of ERα in pituitary tumor cell models |
| BACE1 (β-secretase) | Alzheimer's disease with sex-specific ERE-dependent regulation | Knock-in of ERE variants in neuronal cell models |
| ESR1 (ERα) | Feeding behavior regulation via ERE signaling | Conditional knockout in mouse neuroendocrine circuits |
| ESR2 (ERβ) | Estrogen signaling modulation by phytoestrogens | Overexpression and point-mutation in reporter cell lines |
| ERE-binding protein panel | Breast cancer behavior biomarker | Knockout and overexpression in breast cancer cell lines |
Estrogen response element binding in breast cancer
Estrogen response element binding proteins have been characterized as biomarkers of breast cancer behavior, linking the molecular function GO:0034056 to clinical tumor phenotype. Because ERE binding is the step through which estrogen receptors engage target promoters, alterations in this function can influence estrogen-dependent proliferative programs. The ligand- and sequence-dependent nature of ERE occupancy further suggests that breast cancer cells may exploit specific ERE contexts to sustain estrogen-responsive gene expression.
Estrogen response element binding in prolactinoma
17β-estradiol binding to ERα promotes prolactinoma progression through estrogen-response element-induced CaBP-9k up-regulation. This provides a direct disease example in which ERE binding drives a target-gene program that supports tumor progression. The finding also illustrates how the molecular function defined by GO:0034056 can be mechanistically connected to endocrine tumor biology.
Estrogen response element binding in Alzheimer's disease
Sex-specific regulation of β-secretase involves a novel estrogen response element-dependent mechanism in Alzheimer's disease. This connects ERE binding to neurodegeneration-related gene regulation and highlights sex as a biological variable in ERE-dependent transcription. The observation complements evidence that ERα ERE signaling can control complex behaviors such as feeding in a sex-dependent manner.
Estrogen response element binding in neuroendocrine and behavioral regulation
The influence of estrogen response element ERα signaling on feeding behaviors in male and female mice demonstrates that ERE-dependent transcription contributes to neuroendocrine control of behavior. This broadens the disease and physiology relevance of GO:0034056 beyond classical reproductive tissues. Together with the Alzheimer's disease findings, it supports the view that ERE binding is important in the central nervous system.
From estrogen response element binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is ESR1 required for ERE-dependent target-gene activation? | ESR1 knockout cell line with ERE reporter |
| Does a specific ERE sequence variant alter receptor occupancy? | Point-mutation of the ERE in a knock-in reporter line |
| Can a disease-associated ERE variant reproduce altered regulation? | Knock-in of the variant ERE in neuronal or endocrine cells |
| Where and when does the receptor bind the ERE in vivo? | Tagged knock-in of ESR1 for chromatin occupancy assays |
| Does increased receptor abundance enhance ERE-driven transcription? | Overexpression of ESR1 or ESR2 in reporter cells |
| Does ERE-dependent signaling control a behavioral phenotype? | Conditional knockout in mouse neuroendocrine circuits |
How to Study the estrogen response element binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ERE-binding assay | Physical binding of receptors to ERE sequences | Comparing ERα and ERβ binding responses |
| Ligand-response profiling | Effect of ligands on receptor-ERE interaction | β-estradiol-estrogen receptor complex studies |
| ERE reporter assay | Transcriptional output from an ERE-containing promoter | Testing ERE sequence variants and ligands |
| Target-gene expression analysis | Expression of ERE-regulated genes | CaBP-9k up-regulation in prolactinoma models |
| In vivo occupancy analysis | Receptor binding to regulated genes in cells | Sequence- and ligand-dependent occupancy studies |
| Biomarker profiling | ERE-binding protein patterns associated with phenotype | Breast cancer behavior characterization |
| Sex-specific comparative analysis | Differential ERE-dependent regulation by sex | β-secretase regulation in Alzheimer's disease |
| Behavioral phenotyping | Physiological consequences of ERE signaling | Feeding behavior in male and female mice |
Biochemical ERE-binding assays
ERE binding can be measured biochemically by assessing the interaction of estrogen receptors with ERE-containing sequences, as described for the β-estradiol-estrogen receptor complex and for phytoestrogen modulation of ERα and ERβ binding. These assays define the DNA-binding activity that corresponds to GO:0034056. They are typically used to compare receptor subtypes, ligands, and ERE sequences.
Reporter assays for ERE-dependent transcription
ERE-containing promoter reporters allow researchers to connect ERE binding to transcriptional output. ERE-induced up-regulation of target genes such as CaBP-9k demonstrates how binding events translate into gene expression changes. Reporter systems are also useful for testing sequence variants and ligand effects on ERE-dependent regulation.
In vivo occupancy and target-gene analysis
The interplay between ERE sequence and ligands controls in vivo binding of estrogen receptor to regulated genes, so occupancy should be assessed in the relevant cellular context. Combining occupancy data with expression analysis of estrogen-regulated genes provides a functional readout of ERE binding. This approach is particularly valuable for sex-specific mechanisms such as β-secretase regulation.
Genetic and biomarker-based approaches
Genetic perturbation of receptors and ERE elements can test causality, while ERE-binding protein profiles can be evaluated as biomarkers of disease behavior. Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior illustrates the translational use of this molecular function. Hormone response element binding proteins can also be examined as broader regulators of estrogen and vitamin D signaling.
How CRISPR Can Be Used to Study GO:0034056 estrogen response element binding
Knockout
CRISPR knockout of ESR1 or ESR2 can remove the primary ERE-binding receptors and test whether a given estrogen-regulated gene program depends on ERE binding. Knockout models are also suited to testing whether ERE-dependent mechanisms are required for phenotypes such as feeding behavior or tumor progression. By comparing knockout and wild-type cells, researchers can attribute transcriptional changes to the ERE-binding function defined by GO:0034056.
Point Mutation
Point mutation of the ERE sequence or of the receptor DNA-binding interface can dissect sequence- and ligand-dependent binding, which is known to control in vivo receptor occupancy. Such models help determine whether a specific ERE variant alters regulation in disease contexts such as Alzheimer's disease. Point mutations also allow separation of ERE binding from other receptor activities.
Knock-in
Knock-in of tagged receptors or of disease-associated ERE variants enables precise tracking of ERE occupancy and its transcriptional consequences. This is particularly useful for studying sex-specific ERE-dependent regulation in relevant cell types. Knock-in approaches can also place reporter cassettes under ERE control to quantify binding-driven expression.
Overexpression
Overexpression of ESR1 or ESR2 can test whether increased receptor abundance enhances ERE-dependent transcription and downstream phenotypes. This is relevant to contexts such as prolactinoma, where ERα-ERE signaling promotes progression. Overexpression models also help evaluate phytoestrogen modulation of ERE binding.
How EDITGENE Supports estrogen response element binding Research
Researchers studying estrogen response element binding-related genes often need to determine whether a candidate gene is causally involved in ERE-dependent regulation or merely correlated with it. Establishing causality requires controlled genetic models in which the receptor, the ERE element, or the downstream target is precisely altered. EDITGENE provides the full range of CRISPR-engineered cell models needed to move from correlation to mechanism in ERE biology.
Contact EDITGENE today to design your custom CRISPR model for estrogen response element binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NR6A1 Knockout HEK293 Cell Line | EDJ-KQ1952 | Human | 2649 | Details Get a Quote |
| ESR2 Knockout HEK293 Cell Line | EDJ-KQ2775 | Human | 2100 | Details Get a Quote |
| PGR Knockout HEK293 Cell Line | EDJ-KQ3386 | Human | 5241 | Details Get a Quote |
| ESRRA Knockout HEK293 Cell Line | EDJ-KQ4554 | Human | 2101 | Details Get a Quote |
| ESRRG Knockout HEK293 Cell Line | EDJ-KQ4557 | Human | 2104 | Details Get a Quote |
| ESRRB Knockout HEK293 Cell Line | EDJ-KQ4561 | Human | 2103 | Details Get a Quote |
| NR3C2 Knockout HEK293 Cell Line | EDJ-KQ5218 | Human | 4306 | Details Get a Quote |
| TRIM24 Knockout HEK293 Cell Line | EDJ-KQ6372 | Human | 8805 | Details Get a Quote |
| NR3C1 Knockout HEK293 Cell Line | EDJ-KQ14493 | Human | 2908 | Details Get a Quote |
| AR Knockout HEK293 Cell Line | EDJ-KQ17802 | Human | 367 | Details Get a Quote |
| ESR1 Knockout HEK293 Cell Line | EDJ-KQ17817 | Human | 2099 | Details Get a Quote |
| ESRRA Knockout A-549 Cell Line | EDJ-KQ27194 | Human | 2101 | Details Get a Quote |
| ESRRA Knockout HCT 116 Cell Line | EDJ-KQ27195 | Human | 2101 | Details Get a Quote |
| ESRRA Knockout HeLa Cell Line | EDJ-KQ27196 | Human | 2101 | Details Get a Quote |
| NR3C1 Knockout A-549 Cell Line | EDJ-KQ44755 | Human | 2908 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About estrogen response element binding
What is estrogen response element binding?
Estrogen response element binding (GO:0034056) is the molecular function of binding to an estrogen response element (ERE), a conserved promoter sequence found in genes whose expression is regulated in response to estrogen.
What genes are involved in estrogen response element binding?
The principal genes are ESR1 (ERα) and ESR2 (ERβ), which encode estrogen receptors that bind the ERE; additional hormone response element binding proteins can also regulate this axis.
What is the GO ID for estrogen response element binding?
The GO ID is GO:0034056, and the synonym is ERE binding.
How does estrogen receptor bind to the estrogen response element?
The β-estradiol-estrogen receptor complex binds the ERE, and this interaction is influenced by the exact ERE sequence and the bound ligand.
Is ERE binding the same as estrogen receptor binding?
No. ERE binding specifically refers to binding the estrogen response element DNA sequence, which is the function defined by GO:0034056.
What diseases are linked to estrogen response element binding?
ERE binding has been linked to breast cancer behavior, prolactinoma progression, Alzheimer's disease, and neuroendocrine control of feeding behavior.
Can phytoestrogens affect estrogen response element binding?
Yes, phytoestrogens modulate the binding response of estrogen receptors alpha and beta to the estrogen response element.
How can I study estrogen response element binding in the lab?
Common approaches include biochemical ERE-binding assays, ERE reporter assays, in vivo occupancy analysis, and target-gene expression profiling.
What CRISPR models are useful for ERE binding research?
Knockout, point-mutation, knock-in, and overexpression models of ESR1, ESR2, or ERE elements allow causal testing of ERE-dependent regulation.
Why is estrogen response element binding important in Alzheimer's disease?
A novel ERE-dependent mechanism regulates β-secretase in a sex-specific manner, linking ERE binding to Alzheimer's disease biology.
Conclusion
Estrogen response element binding (GO:0034056) is a defined molecular function that connects estrogen signaling to promoter-specific gene regulation. The verified literature shows that this function is mediated primarily by ERα and ERβ, is sensitive to ERE sequence and ligand identity, and is modulated by compounds such as phytoestrogens. Its biological importance spans cell proliferation, neuroendocrine behavior, and disease processes including prolactinoma, Alzheimer's disease, and breast cancer. Because ERE binding is experimentally tractable, CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide a direct route to causal understanding. Researchers can now pair these genetic models with biochemical and transcriptional assays to dissect how ERE binding shapes normal physiology and disease.
References
- 1. Lisse TS et al.. 2011. Hormone response element binding proteins: novel regulators of vitamin D and estrogen signaling.. Steroids 76(4):331-9 PMID: 21236284
- 2. Heger Z et al.. 2013. Molecular biology of beta-estradiol-estrogen receptor complex binding to estrogen response element and the effect on cell proliferation.. Neuro Endocrinol Lett 34 Suppl 2:123-9 PMID: 24362104
- 3. Yasrebi A et al.. 2023. The influence of estrogen response element ERα signaling in the control of feeding behaviors in male and female mice.. Steroids 195:109228 PMID: 36990195
- 4. Cui J et al.. 2022. Sex-Specific Regulation of β-Secretase: A Novel Estrogen Response Element (ERE)-Dependent Mechanism in Alzheimer's Disease.. J Neurosci 42(6):1154-1165 PMID: 34903570
- 5. Liu J et al.. 2020. 17β-estradiol binding to ERα promotes the progression of prolactinoma through estrogen-response element-induced CaBP-9k up-regulation.. Biosci Rep 40(1) PMID: 31894842
- 6. Kruer TL et al.. 2013. Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior.. Clin Biochem 46(16-17):1739-46 PMID: 23868020
- 7. Kostelac D et al.. 2003. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.. J Agric Food Chem 51(26):7632-5 PMID: 14664520
- 8. Krieg AJ et al.. 2004. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.. J Biol Chem 279(6):5025-34 PMID: 14617632
